Workflow
Elis: Annual shareholders meeting of May 22, 2025
Globenewswire· 2025-05-22 16:02
Core Points - The combined shareholders' meeting of Elis took place on May 22, 2025, with a quorum of 87%, and all resolutions were approved [2] Financial Results - The annual and consolidated financial statements for fiscal year 2024 were approved, along with a distribution of €0.45 per share, to be detached on May 26, 2025, and paid on May 28, 2025 [3] Board Composition - The Supervisory Board of Elis consists of 14 members, including 8 independent members, 6 women, and 2 employee representatives, reflecting the Group's diversity policy [3] Compensation Policy - The shareholders approved the compensation policy for the Company's executive officers for 2025, including fixed, variable, and exceptional elements of total compensation for the financial year 2024 [4] Share Buyback and Capital Management - The renewal of the authorization for share buybacks and the delegation for issuing shares and securities for foreign employees were approved, along with the authority to reduce share capital through share cancellations [5] Board Appointments - The reappointment of Anne-Laure Commault-Tingry and Michel Plantevin as Supervisory Board members for four years was approved, along with the appointment of BWSA represented by Alexis Martineau, and two new members, Isabelle Adelt and Kelly Becker, for three years [6] Statutory Auditors - The reappointment of Forvis-Mazars and PricewaterhouseCoopers Audit as Statutory Auditors for a term of six years to certify financial statements and sustainability information was approved [6]
AM Best affirms ratings of Coface’s main operating subsidiaries
Globenewswire· 2025-05-22 16:00
Core Viewpoint - AM Best has affirmed the Financial Strength Rating of A (Excellent) and Long-Term Issuer Credit Ratings of 'a+' (Excellent) for Coface and its main operating subsidiaries, indicating a stable outlook for these ratings [2][3]. Group Performance - The ratings reflect Coface group's very strong balance sheet strength, strong operating performance, favorable business profile, and appropriate enterprise risk management [3]. - Coface's consolidated risk-adjusted capitalization is assessed at the strongest level according to the Best's Capital Adequacy Ratio (BCAR) score [3]. Market Position - Coface holds a leading position in the global credit insurance market, characterized by high barriers to entry, which supports its strong ratings [5]. Future Outlook - AM Best acknowledges that the group's prospective performance may experience volatility due to an uncertain global operating environment, but expects cross-cycle performance metrics to remain supportive of the strong assessment [4].
AKVA group ASA: Minutes from annual general meeting
Globenewswire· 2025-05-22 16:00
Group 1 - The annual general meeting of AKVA group ASA was held on 22 May 2025 [1] - All items on the agenda were approved in accordance with the proposals set out in the notice of the annual general meeting [1] - The minutes from the meeting will be made available on the company's website [1] Group 2 - Contact information for the Chief Executive Officer and Chief Financial Officer is provided, including phone numbers and email addresses [1] - The information is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act [1]
30-Year Fixed-Rate Mortgages Average 6.86%
Globenewswire· 2025-05-22 16:00
Core Insights - Freddie Mac's Primary Mortgage Market Survey indicates that the 30-year fixed-rate mortgage (FRM) averaged 6.86% as of May 22, 2025, showing an increase from 6.81% the previous week but remaining lower than the 6.94% average from a year ago [1][4] - The 15-year FRM also saw an increase, averaging 6.01% compared to 5.92% the previous week and 6.24% a year ago [4] - The increase in mortgage rates is accompanied by a greater inventory for buyers, which has helped maintain purchase application activity [1] Industry Overview - The PMMS focuses on conventional, conforming, fully amortizing home purchase loans for borrowers with excellent credit who put 20% down [2] - Freddie Mac's mission is to enhance liquidity, stability, and affordability in the housing market across various economic cycles, having assisted millions of families since 1970 [3]
Toll Brothers Announces Last Chance to Build a New Luxury Home at Laurel Pointe in Orlando, Florida
Globenewswire· 2025-05-22 15:57
Core Insights - Toll Brothers, Inc. has announced the final opportunity to build new homes in Laurel Pointe, an exclusive community in Lake Nona, Orlando, Florida, with limited homes available for sale, including the Marsanne Farmhouse model [1][2] Company Overview - Toll Brothers, Inc. is recognized as the nation's leading builder of luxury homes and is a Fortune 500 Company, founded in 1967 and publicly traded since 1986 [8][9] - The company operates in over 60 markets across 24 states and the District of Columbia, offering a range of housing options for various buyer segments [8] Community Features - Laurel Pointe features home designs from the Collage Collection, with prices starting from $1.7 million, offering high-end interiors and smart home features [2][4] - The community is conveniently located near A-rated schools, Orlando International Airport, and major highways, providing easy access to shopping, dining, and recreational destinations [4] Lake Nona Overview - Lake Nona is recognized as a smart city and one of the fastest-growing master-planned communities in the U.S., covering 17 square miles and hosting a collaborative network of businesses in healthcare, sports, and transportation [5] - Residents of Laurel Pointe will have access to Lake Nona's extensive amenities, including trails, parks, and wellness programs [5]
Euronext announces the success of its offering of bonds due 2032 convertible into new shares and/or exchangeable for existing shares (“OCEANEs”) for a nominal amount of €425 million
Globenewswire· 2025-05-22 15:57
Core Points - Euronext successfully completed an offering of senior unsecured bonds convertible into shares for a nominal amount of €425 million [1][2] - The proceeds from the bond offering will be used to repay part of a bridge loan and for general corporate purposes [2] Bond Terms - The bonds will have a denomination of €100,000 each, a fixed coupon rate of 1.50% per annum, and will pay interest semi-annually [3] - The initial conversion price is set at €191.1654, representing a 35% premium over the reference share price of €141.6040 [4] - The bonds will be redeemed at par on 30 May 2032 unless converted or exchanged earlier [5] Early Redemption and Conversion Rights - The company can redeem the bonds early under certain conditions, including if the average share price exceeds 130% of the conversion price [6] - Bondholders can convert or exchange their bonds into shares from 41 days after the issue date until 7 business days before maturity [7] Conversion Ratio and Dilution - The conversion ratio is set at approximately 523.1072 shares per bond, subject to adjustments [8] - The potential dilution from the bond offering is estimated at around 2.1% of the company's outstanding share capital if all bonds are converted [14] Legal and Regulatory Framework - The bonds are offered only to qualified investors and will not be publicly offered in certain jurisdictions [11][16] - Existing shareholders do not have preferential subscription rights for the bonds or any new shares issued upon conversion [12] Lock-up and Trading - The company has agreed to a lock-up period for its shares for 90 days following the issue date [13] - Application will be made for the bonds to be traded on Euronext Access in Paris within 30 days from the issue date [9]
FDA approves Roche’s Susvimo for diabetic retinopathy
Globenewswire· 2025-05-22 15:45
Susvimo can help people with diabetic retinopathy (DR) maintain their vision and prevent progression to blindness with only one treatment every nine monthsSusvimo’s innovative technology via the Port Delivery Platform may offer an alternative to regular eye injections in the USDiabetic retinopathy affects almost 10 million people in the US and is the third FDA-approved indication for Susvimo, which is also approved for treating neovascular or ‘wet’ age-related macular degeneration and diabetic macular edema ...
Transgene to Present 24-month Disease-Free Survival Data from All Patients in Phase I Part of Trial of Individualized Cancer Vaccine, TG4050, at ASCO 2025
Globenewswire· 2025-05-22 15:45
24-month follow-up data from randomized Phase I part of the Phase I/II trial of TG4050 in resected locally advanced head and neck cancer selected for rapid oral presentationat ASCO on June 1st, 2025 Strasbourg, France, May 22, 2025, 5:45 p.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announces that it will present two-year disease-free survival (DFS) data from all patients in the randomized Phase I part o ...
Touax: availibility of documents shareholder's meeting 12 06 2025
Globenewswire· 2025-05-22 15:45
REGULATED INFORMATION Paris, 22 May 2025 5:45 PM YOUR OPERATIONAL LEASING SOLUTION FOR SUSTAINABLE TRANSPORTATION Availability of documents Annual shareholders’ meeting of June 12th, 2025 TOUAX informs its shareholders that its combined Annual Shareholders’ Meeting will be held on Thursday June 12, 2025 at 3:00 p.m. at Châteauform' Learning Lab La Défense, 40 passage de l’Arche, 92800 Puteaux, France. The official meeting announcements have been published in the BALO (Bulletin des Annonces Légales Obligat ...
SKEL fjárfestingafélag hf.: Orkan signs purchase agreement for shares in Samkaup
Globenewswire· 2025-05-22 15:34
Following previous discussions between SKEL fjárfestingafélag hf. (“SKEL”) and Samkaup hf. (“Samkaup”) regarding a merger of Samkaup with Orkan IS ehf. (“Orkan”) and Atlaga ehf. (formerly Heimkaup), further discussions took place with Kaupfélag Suðurnesja svf. (“KSK”), the largest shareholder in Samkaup, about resuming the dialogue under new terms. This past December, the parties reached an agreement on a merger between Atlaga and Samkaup, a transaction that received competition authority approval in April. ...